Senescence-associated signature based on immunotherapy response sequencing reveals PPIL3 as target for bladder cancer treatment and prognosis prediction

Senescence-associated signature based on immunotherapy response sequencing reveals PPIL3 as target for bladder cancer treatment and prognosis prediction

BackgroundBladder cancer (Bca) remains a major genitourinary malignancy with unmet needs in immunotherapy optimization. Despite advancements in immune checkpoint inhibitors (ICIs), challenges persist, including low response rates and drug resistance. Emerging evidence links tumor cell senescence to...

Full description

Saved in:
Bibliographic Details
Main Authors: Kaixuan Du, Ning Kang, Yuda Lin, Kaipeng Jia, Chong Shen, Zhouliang Wu, Hailong Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
senescence
immunotherapy
bladder cancer
PPIL3
therapeutic target
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1613056/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items